Predictors of Clinical Remission to Placebo in Clinical Trials of Crohn's Disease.
Emily C L WongParambir S DulaiJohn K MarshallVipul JairathWalter ReinischNeeraj NarulaPublished in: Inflammatory bowel diseases (2022)
Strategies that reduce placebo response rates in clinical trials of CD should be considered, including stratification or exclusion of subjects by disease duration and mild disease severity as measured by objective biomarkers.